NCT03942497View on ClinicalTrials.gov

Clinical-pathological Characterization and Outcomes of Metastatic Urothelial Cancer in Latin America

CompletedOBSERVATIONAL
Enrollment

218

Participants

Timeline

Start Date

August 1, 2019

Primary Completion Date

August 31, 2021

Study Completion Date

February 28, 2022

Conditions
Recurrent/Metastatic Urothelial Cancers
Trial Locations (9)

Unknown

CLION, Salvador

Clínica AMO, Salvador

Hospital São Rafael, Salvador

LIGA, Curitiba

CPO Pucrs, Porto Alegre

CEPON, Florianópolis

Beneficência Portuguesa, São Paulo

Centro Paulista de Oncologia, São Paulo

Sírio Libanês, São Paulo

All Listed Sponsors
collaborator

Janssen-Cilag Ltd.

INDUSTRY

lead

Latin American Cooperative Oncology Group

OTHER

NCT03942497 - Clinical-pathological Characterization and Outcomes of Metastatic Urothelial Cancer in Latin America | Biotech Hunter | Biotech Hunter